(442 days)
Not Found
No
The description focuses on the physical characteristics and materials of a guidewire, with no mention of software, algorithms, or data processing that would indicate AI/ML. The performance studies are standard mechanical and biocompatibility tests for a physical medical device.
No.
The device is described as a guidewire intended to introduce and position other medical devices, not to directly treat a medical condition.
No
The device description clearly states it is "used to introduce and position catheters and other interventional devices," and "to facilitate the introduction and placement of devices." While it can be used in "diagnostic and interventional procedures," its primary function described is to aid in the delivery of other tools, not to diagnose a condition itself.
No
The device description clearly outlines a physical medical device consisting of a stainless-steel core wire with a distal coil and PTFE coating, intended for introduction into the heart. It also details extensive mechanical, physical, and biocompatibility testing, which are characteristic of hardware devices, not software-only devices.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for diagnostic purposes. This examination is performed outside of the living body (in vitro).
- ProTrack™ Pigtail Wire Function: The ProTrack™ Pigtail Wire is a medical device used within the human body (in vivo) to guide and position other devices during interventional procedures in the heart. It is a tool for facilitating a procedure, not for analyzing a specimen to diagnose a condition.
The description clearly states its purpose is to "introduce and position catheters and other interventional devices within the chambers of the heart." This is an interventional, not a diagnostic, function performed in vivo.
N/A
Intended Use / Indications for Use
The ProTrack™ Pigtail Wires are intended for use to introduce and position catheters and other interventional devices within the chambers of the heart, including those used within transcatheter aortic valve procedures (TAVR).
Product codes (comma separated list FDA assigned to the subject device)
DOX
Device Description
The ProTrack™ Pigtail Wire is a single used for the patients requiring diagnostic and interventional procedures like transcatheter aortic valve replacement (TAVR). It is used to facilitate the introduction and placement of devices in catheterization procedures primarily by Electrophysiologists and Interventional Cardiologists. Procedures using the devices are performed in fully equipped catheter labs with imaging equipment, including fluoroscopy and echocardiography under sterile technique.
The device consists of a stainless-steel core wire with a flexible, spiral shaped stainless steel distal coil. A green PTFE coating is present on the entire length of the device and provides a lubricious surface for smooth tracking through accessory devices and vasculature. The Wire has a radiopaque coil (304V Stainless Steel) around the distal curve to allow visualization under appropriate imaging guidance during procedures. The device is offered in multiple models with two different lengths (230 cm and 275 cm), diameters (0.032″ and 0.035″), and distal curve shapes (regular and small). The device is provided sterilized).
The wire is classified as an external communicating device, contacting circulating blood, with limited exposure and contact up to a maximum of 24 hours. The patient contacting materials are PTFE coating, stainless steel and adhesive.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
fluoroscopy and echocardiography
Anatomical Site
chambers of the heart
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Electrophysiologists and Interventional Cardiologists. Procedures using the devices are performed in fully equipped catheter labs with imaging equipment, including fluoroscopy and echocardiography under sterile technique.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance Testing has been completed to demonstrate substantial equivalence of the subject device and predicate device. All test requirements were met as specified by applicable standard and the test protocols. The device was subjected to the following verification and validation activities:
Mechanical Testing per 11070:2014/Amd:2018 (Corrosion Resistance, Flex Test, Fracture test, Peak tensile force, Tensile strength, Tip Pull) and per FDA guidance Coronary, Peripheral, and Neurovascular Guidewires -Performance Tests and Recommended Labeling (Dimensional verification, Visual inspection, Repeated Simulated Use, Peak tensile force/Tensile strength, Tip pull, Torque Strength, Coating integrity, Particulate testing, Lubricity/Friction testing, Corrosion resistance, Kink resistance, Tip flexibility, Radiopacity).
General Physical Testing: Curve Retention, Flexural rigidity.
Biocompatibility Verification: ISO Cytotoxicity study, ISO Maximization Sensitization Study, ISO Intracutaneous Reactivity Study, ISO/USP Material Mediated Pyrogenicity, ISO Hemocompatibility Study, ISO Acute Systemic Toxicity Study.
Sterilization Verification to the requirements of ISO 11134-1:2014. Sterilization is performed with Ethylene Oxide to a Sterility Assurance Level (SAL) of 10-6. Residual limits are in accordance with ISO 10993-7:2008.
Pyrogen Testing: Limulus Amoebocyte Lysate (LAL) testing using the Kinetic Chromogenic method, as per ANSI/AAMI ST72:2019 and FDA guidance.
Packaging Verification: Ship testing, seal strength, and sterile barrier integrity evaluated per ISO 11607-1:2020 and ISO 11607-2:2017.
Bench-top Validation: User needs for ProTrack™ Pigtail Wire were validated through benchtop validation activities. Users familiar with catheter-based interventional procedures performed a sequence of actions with a benchtop model representative of a clinical workflow, and observations regarding ease of use and errors were recorded and evaluated to conclude if customer requirements were met.
Key Results: The validation testing demonstrated that the ProTrack™ Pigtail Wire meets the intended use to support substantial equivalence.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.1330 Catheter guide wire.
(a)
Identification. A catheter guide wire is a coiled wire that is designed to fit inside a percutaneous catheter for the purpose of directing the catheter through a blood vessel.(b)
Classification. Class II (special controls). The device, when it is a torque device that is manually operated, non-patient contacting, and intended to manipulate non-cerebral vascular guide wires, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.
0
Image /page/0/Picture/0 description: The image contains the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in blue, with the word "ADMINISTRATION" underneath. The logo is simple and professional, and it is easily recognizable.
March 1, 2023
Baylis Medical Company Inc. May Tsai Director of Regulatory Affairs 5825 Explorer Dr. Mississauga, Ontario L4W 5P6 Canada
Re: K213898
Trade/Device Name: ProTrack Pigtail Wire Regulation Number: 21 CFR 870.1330 Regulation Name: Catheter guide wire Regulatory Class: Class II Product Code: DOX Dated: February 1, 2023 Received: February 1, 2023
Dear May Tsai:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal
1
statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Jennifer Bastijanic -S
for Jaime Raben Assistant Director DHT2B: Division of Circulatory Support, Structural and Vascular Devices OHT2: Office of Cardiovascular Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K213898
Device Name ProTrack™ Pigtail Wire
Indications for Use (Describe)
The ProTrack™ Pigtail Wires are intended for use to introduce and position catheters and other interventional devices within the chambers of the heart, including those used within transcatheter aortic valve procedures (TAVR).
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(K) SUMMARY
Submitter Information
| A. Company Name: | Baylis Medical Company Inc. |
|---|---|
| B. Company Address: | 5825 Explorer Dr |
| Mississauga, Ontario, L4W 5P6 | |
| Canada | |
| C. Company Phone: | +1 (905) 602-4875 |
| D. Company Facsimile: | +1 (905) 602-5671 |
| E. Contact Person: | May Tsai |
| Director, Regulatory Affairs | |
| F. Summary Prepared on: | 23-Feb-2023 |
Device Identification
| A. Device Trade Name: | ProTrack™ Pigtail Wire |
|---|---|
| B. Device Common Name: | Guidewire |
| C. Classification Name: | Wire, Guide, Catheter (21 CFR 870.1330) |
| D. Product Code: | DQX |
| E. Review Panel: | Cardiovascular |
| F. Device Class: | Class II |
Identification of Legally Marketed Device
| A. Predicate Device: | Medtronic Confida™ Brecker Curve™ Guidewire |
|---|---|
| B. Manufacturer: | Medtronic |
| C. 510(k) | K132623 |
| D. Indications for Use | The Medtronic Confida™ Brecker Curve™ Guidewire |
| is intended for use to introduce and position | |
| catheters during diagnostic and-interventional | |
| procedures within the chambers of the heart, | |
| including, transcatheter aortic valve implantation | |
| (TAVI). |
4
Intended Use
The ProTrack™ Piqtail Wires are intended to facilitate the placement of devices during diagnostic and interventional procedures.
Indications for Use
The ProTrack™ Pigtail Wires are intended for use to introduce and position catheters and other interventional devices within the chambers of the heart, including those used within transcatheter aortic valve procedures (TAVR).
Device Description
The ProTrack™ Pigtail Wire is a single used for the patients requiring diagnostic and interventional procedures like transcatheter aortic valve replacement (TAVR). It is used to facilitate the introduction and placement of devices in catheterization procedures primarily by Electrophysiologists and Interventional Cardiologists. Procedures using the devices are performed in fully equipped catheter labs with imaging equipment, including fluoroscopy and echocardiography under sterile technique.
The device consists of a stainless-steel core wire with a flexible, spiral shaped stainless steel distal coil. A green PTFE coating is present on the entire length of the device and provides a lubricious surface for smooth tracking through accessory devices and vasculature. The Wire has a radiopaque coil (304V Stainless Steel) around the distal curve to allow visualization under appropriate imaging guidance during procedures. The device is offered in multiple models with two different lengths (230 cm and 275 cm), diameters (0.032″ and 0.035″), and distal curve shapes (regular and small). The device is provided sterilized).
The wire is classified as an external communicating device, contacting circulating blood, with limited exposure and contact up to a maximum of 24 hours. The patient contacting materials are PTFE coating, stainless steel and adhesive.
Comparison of Technological Characteristic with Predicate Device
The subject ProTrack™ Pigtail Wire and predicate device Confida™ Brecker Curve™ Guidewire have the same intended use, fundamental scientific technology, sterility and principle of operation. Differences in design and technological characteristics between the subject and predicate device do not raise any new types of questions of safety and effectiveness. The results of verification and validation testing provide reasonable assurance of the safe and
5
effective use of the ProTrack™ Pigtail Wire to establish substantial equivalence for its intended use to the predicate device. Table 1 below shows technological comparison of subject device with predicate device.
| Characteristic | Comparison Result | Comment |
|---|---|---|
| Intended Use | Identical | The subject and predicate device are both |
| intended to facilitate the placement of | ||
| devices during diagnostic and | ||
| interventional procedures. | ||
| Indications for Use | Similar | The indications for use of the subject |
| device is similar to that of the predicate | ||
| device, with minor wording differences to | ||
| clarify the devices that can be positioned. | ||
| The terms TAVI (used in predicate device | ||
| labelling) and TAVR (used in subject | ||
| device labelling) are considered | ||
| equivalent. | ||
| Fundamental Scientific | ||
| Technology | Identical | Both subject and predicate device rely on |
| user controlled mechanical manipulation | ||
| to percutaneously gain access to | ||
| vasculature and chambers of heart. | ||
| Operating Principles | Identical | Both subject and predicate device |
| facilitate the introduction and positioning | ||
| of one catheter and/or interventional | ||
| device for another, while maintaining | ||
| guidewire position in the chambers of the | ||
| heart. | ||
| Mechanism of Action | Identical | The mechanism of action for both subject |
| and predicate device is mechanical force. | ||
| Environment of Use | Identical | Both subject and predicate device are used |
| in facilities equipped and staffed to | ||
| perform diagnostic and interventional | ||
| procedures. | ||
| Materials | Similar | The subject and predicate device are both |
| comprised of the following materials: | ||
| • Stainless steel | ||
| • PTFE coating |
The following material is different:
• Adhesive |
| Technological
characteristics | Similar | Both subject and predicate device share
the same characteristic:
• Distal tip configuration
The following characteristics are different:
• Device usable Length
• Outer diameter
• Distal tip spiral diameter
• Compatibility with accessory
device |
| Packaging | Similar | The subject and predicate device
packaging system differ in:
• Packaging material
• Packaging configuration |
| Sterilization | Identical | Both subject and predicate device are
Single Use, Ethylene Oxide sterilized |
Table 1: Comparison of Technological Characteristics with Predicate Device
6
7
Performance Testing Summary
Performance Testing has been completed to demonstrate substantial equivalence of the subject device and predicate device. All test requirements were met as specified by applicable standard and the test protocols. The device was subjected to the following verification and validation activities.
Mechanical Testing
Mechanical verification testing was conducted for the ProTrack™ Pigtail Wire to ensure compliance with the requirements per FDA guidance and ISO 11070:2014/Amd:2018. The following mechanical tests were performed for the device:
Per 11070:2014/Amd:2018:
- Corrosion Resistance .
- Flex Test .
- Fracture test ●
- Peak tensile force
- Tensile strength .
- Tip Pull ●
Per FDA guidance Coronary, Peripheral, and Neurovascular Guidewires -Performance Tests and Recommended Labeling:
- . Dimensional verification
- Visual inspection .
- Repeated Simulated Use .
- Peak tensile force/Tensile strength ●
- Tip pull .
- Torque Strength .
- Coating integrity ●
- Particulate testing ●
- Lubricity/Friction testing
- Corrosion resistance
- Kink resistance .
- Tip flexibility .
- Radiopacity ●
8
General Physical Testing
General physical verification testing was conducted for the ProTrack™ Pigtail Wire to ensure compliance with Baylis Medical Company Inc. self-enforced requirements. The following tests were performed:
- . Curve Retention
- . Flexural rigidity
Biocompatibility Verification
The biological safety of the ProTrack™ Pigtail Wire was verified in accordance with the requirements of ISO 10993-1:2020 and the FDA guidance document, Use of International Standard ISO 10993-1, "Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process". The following biocompatibility tests were performed:
- . ISO Cytotoxicity study
- ISO Maximization Sensitization Study .
- ISO Intracutaneous Reactivity Study
- ISO/USP Material Mediated Pyrogenicity .
- ISO Hemocompatibility Study ●
- . ISO Acute Systemic Toxicity Study
Sterilization Verification
Sterilization verification was completed for the ProTrack™ Pigtail Wire to the requirements of ISO 11134-1:2014. Sterilization is performed with Ethylene Oxide to a Sterility Assurance Level (SAL) of 10-6. Residual limits are in accordance with ISO 10993-7:2008.
Pyrogen Testing
The ProTrack™ Pigtail Wire is supplied non-pyrogenic. Limulus Amoebocyte Lysate (LAL) testing was evaluated using the Kinetic Chromogenic method, as per ANSI/AAMI ST72:2019 and the FDA guidance document, "Guidance for Industry – Pyrogens and Endotoxins Testing: Questions and Answers," to verify the subject device meets current FDA and USP pyrogen limit specifications.
9
Packaging Verification
Ship testing was evaluated to verify the integrity of the subject device packaging through the rigors of shipping and handling as well as storage over time. The seal strength and sterile barrier integrity was also evaluated to verify compliance with the current applicable requirements of ISO 11607-1:2020 and ISO 11607-2:2017 over the proposed intended shelf life of the subject device.
Bench-top Validation
User needs for ProTrack™ Piqtail Wire were validated through benchtop validation activities. Users drawn from populations familiar with catheter-based interventional procedures were presented with a sequence of actions to perform with a benchtop model representative of a clinical workflow involving the device. Observations regarding ease of use and errors made were recorded and evaluated to conclude if customer requirements were met. The validation testing demonstrated that the ProTrack™ Pigtail Wire meets the intended use to support substantial equivalence.
Conclusion
The intended use and fundamental scientific technology, including principles of operation and mechanism of action, of the subject ProTrack™ Pigtail Wire are identical to those of the predicate Medtronic Confida™ Brecker Curve™ Guidewire (K132623). Differences in design and technological characteristics do not raise any different questions of safety and effectiveness. The results of verification and validation activities support the substantial equivalence of the subject and the predicate device.